9,516 Results

The FDA has agreed to a rolling submission for givosiran for acute hepatic porphyria.- Alnylam Pharma

 Added 21 hours ago

Alnylam Pharmaceuticals, Inc.has announced that in consultation with the FDA, the Company plans to pursue a full approval based on...

Anixa Biosciences has filed an IVD pre-submission with the FDA for use of its Cchek artificial intelligence based cancer detection technology, as a prostate cancer test.

 Added ago

Anixa Biosciences formerly ITUS Corporation , a biotechnology company focusing on cancer diagnostics for all cancers and CAR-T cell immunotherapy...

European Commission approves Hulio (adalimumab biosimilar)for all indications of the reference drug.- Mylan + Fujifilm Kyowa Kirin Biologics.

 Added 21 hours ago

The European commission (EC) has granted marketing authorization to Mylan and Fujifilm Kyowa Kirin Biologics for Hulio, a biosimilar to...

FDA approves Yutiq for chronic non-infectious uveitis.- EyePoint Pharma.

 Added 21 hours ago

EyePoint Pharmaceuticals announced that the FDA has approved Yutiq (fluocinolone acetonide intravitreal implant) for the treatment of chronic non-infectious uveitis...

Phase III SAkuraSky Study shows SA 237 cuts risk of relapse in neuromyelitis optica.- Chugai Pharma.

 Added 21 hours ago

Chugai Pharmaceutical announced new results from the phase III study of SA 237 (satralizumab) SAkuraSky Study (NCT02028884) for the treatment...

FDA approves Xarelto to reduce the risk of CV events.- Bayer Healthcare + Janssen

 Added 21 hours ago

The FDA has approved rivaroxaban (Xarelto), 2.5 mg twice daily, plus aspirin low dose once daily to reduce the risk...

Phase III KATHERINE study of Kadcyla meets primary endpoint in HER2+ breast cancer.- Genentech/Roche.

 Added 21 hours ago

Genentech/Roche announced the Phase III KATHERINE study met its primary endpoint, showing Kadcyla (ado-trastuzumab emtansine) as a single agent significantly...

Alliqua merges with Adynxx to create a new company to promote brivoligide for the reduction of long term pain relief and the reduction of opioids.

 Added 1 day ago

Alliqua BioMedical, Inc. and Adynxx, Inc., a privately held biopharmaceutical company, announced that they have entered into a definitive merger...

For children and adolescents with type 1 diabetes, Fiasp could be an option to better manage their blood sugar levels.- Novo Nordisk

 Added 21 hours ago

For children and adolescents (1 to less then 18 years old) living with type 1 diabetes, Fiasp (an ultra-fast acting...

FDA Advisory Committee negative for oliceridine to treat moderate to severe acute pain.- Trevena Inc.

 Added 2 days ago

Trevena, Inc. announced the outcome of the meeting of the FDA Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) to...

Load more